HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuusuke Umeda Selected Research

trelagliptin

3/2020Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end-stage renal disease: Results from a randomized, phase 3 study.
10/2018Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuusuke Umeda Research Topics

Disease

1Chronic Kidney Failure (Chronic Renal Failure)
03/2020
1Diabetes Mellitus
03/2020
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2019
1Type 2 Diabetes Mellitus (MODY)
10/2018
1Essential Hypertension
01/2018

Drug/Important Bio-Agent (IBA)

2trelagliptinIBA
03/2020 - 10/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2020
1CreatinineIBA
03/2020
1Renin InhibitorsIBA
01/2019
1Insulin (Novolin)FDA Link
10/2018
1Angiotensin Receptor AntagonistsIBA
01/2018
1azilsartanIBA
01/2018
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2018
1DiureticsIBA
01/2018
1Hydrochlorothiazide (Esidrix)FDA LinkGeneric
01/2018
1Amlodipine (Norvasc)FDA LinkGeneric
01/2018

Therapy/Procedure

2Therapeutics
10/2018 - 01/2018
1Renal Dialysis (Hemodialysis)
03/2020
1Exercise Therapy (Therapy, Exercise)
03/2020